Ads
related to: programmed cell death protein 1
Search results
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 6 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 2 days agoEtrumadenant is an investigational small molecule, selective dual antagonist of the A2a and A2b...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 6 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 2 days agoTwo grade 5 adverse events (AEs) resulting in death occurred during the trials due to interstitial...
... Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line...
Morningstar· 3 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC ...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 5 days agoThe experimental cancer-killing pill is taken twice a day and blocks a protein called proliferating ...
Are You Getting Enough Iodine From Your Diet?
Mercola· 2 days agoUnfortunately, data collected by the U.S. National Health and Nutrition Examination Survey has revealed a significant drop in median urine iodine values.1 The median iodine ...
Salvianolic acid A inhibits ferroptosis and protects against intracerebral hemorrhage - Scientific...
Nature· 7 days agoFerroptosis is a regulated type of iron-dependent, non-apoptotic programmed cell death. There is increasing evidence that ferroptosis ...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 4 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
Multicancer early detection tests for cancer diagnosis
Medical Xpress· 5 days agoCancer is characterized by the uncontrolled proliferation and spread of abnormal cells within the body. Malignant tumors, unlike benign ones, invade nearby tissues and spread to other parts ...
